Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs
WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs
The World Health Organization (WHO) has announced the next phase in its Solidarity trial.
Moderna moving mRNA vaccine candidates for HIV into the clinic
Moderna moving mRNA vaccine candidates for HIV into the clinic
Moderna's experimental vaccines mRNA-1644 and mRNA-1644v2-Core have advanced into Phase I testing, according to a posting Wednesday on the ClinicalTrials.
FDA Approval of Jazz's Xywav Will Leave More People Sleeping Less
FDA Approval of Jazz's Xywav Will Leave More People Sleeping Less
The U.
SARS-CoV-2 Iota variant increases mortality risk among older adults
SARS-CoV-2 Iota variant increases mortality risk among older adults
A study conducted at the New York City Department of Health and Mental Hygiene, USA, and the Mailman School of Public Health, Columbia University, USA, has determined the transmission rate, immune esc...
FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney Disease
FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney Disease
SAN FRANCISCO, Aug.
Moderna to bring mRNA vaccine manufacturing facility to Canada
Moderna to bring mRNA vaccine manufacturing facility to Canada
Moderna have announced a Memorandum of Understanding (MoU) with the government of Canada to build a state-of-the-art messenger RNA (mRNA) vaccine manufacturing facility in Canada, incl...
MHRA approves for Epidyolex® (cannabidiol) for TSC seizure treatment
MHRA approves for Epidyolex® (cannabidiol) for TSC seizure treatment
GW Pharmaceuticals, now part of Jazz Pharmaceuticals, has announced that the UK’s Medicine and Healthcare products Regulatory Agency (MHRA) has approved a new indication for Epidyolex® (...
Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy
Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy
LAKEWOOD, Colo.
AbbVie ditches late-stage eye drug license, collab with Molecular Partners
AbbVie ditches late-stage eye drug license, collab with Molecular Partners
Ten years, two promising phase 3 trials and an FDA complete response letter later and AbbVie has decided to ditch an eye disease drug with Molecular Partners.
BioNTech Soars As It Says It’s Developing Updated Covid Shot For Delta
BioNTech Soars As It Says It’s Developing Updated Covid Shot For Delta
Investing.
Seagen and RemeGen Announce Exclusive Worldwide License and Co-Development Agreement for Disitamab Vedotin
Seagen and RemeGen Announce Exclusive Worldwide License and Co-Development Agreement for Disitamab Vedotin
BOTHELL, Wash.
Nearly 60% of Americans at least partially vaccinated against COVID-19 - CDC
Nearly 60% of Americans at least partially vaccinated against COVID-19 - CDC
(Reuters) - Nearly 60% of the U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand